Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP352069.RAC8hK5EPWXRb060w955P94WF3gJ5p6YIXWRr1HiKSbpo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP352069.RAC8hK5EPWXRb060w955P94WF3gJ5p6YIXWRr1HiKSbpo130_assertion type Assertion NP352069.RAC8hK5EPWXRb060w955P94WF3gJ5p6YIXWRr1HiKSbpo130_head.
- NP352069.RAC8hK5EPWXRb060w955P94WF3gJ5p6YIXWRr1HiKSbpo130_assertion description "[High level phenotypic biomarkers such as cadherins are needed to identify individuals at risk for biologically active prostate cancer and determine which individuals with elevated prostate specific antigen or a prostate nodule are candidates for re-biopsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP352069.RAC8hK5EPWXRb060w955P94WF3gJ5p6YIXWRr1HiKSbpo130_provenance.
- NP352069.RAC8hK5EPWXRb060w955P94WF3gJ5p6YIXWRr1HiKSbpo130_assertion evidence source_evidence_literature NP352069.RAC8hK5EPWXRb060w955P94WF3gJ5p6YIXWRr1HiKSbpo130_provenance.
- NP352069.RAC8hK5EPWXRb060w955P94WF3gJ5p6YIXWRr1HiKSbpo130_assertion SIO_000772 11956481 NP352069.RAC8hK5EPWXRb060w955P94WF3gJ5p6YIXWRr1HiKSbpo130_provenance.
- NP352069.RAC8hK5EPWXRb060w955P94WF3gJ5p6YIXWRr1HiKSbpo130_assertion wasDerivedFrom befree-2016 NP352069.RAC8hK5EPWXRb060w955P94WF3gJ5p6YIXWRr1HiKSbpo130_provenance.
- NP352069.RAC8hK5EPWXRb060w955P94WF3gJ5p6YIXWRr1HiKSbpo130_assertion wasGeneratedBy ECO_0000203 NP352069.RAC8hK5EPWXRb060w955P94WF3gJ5p6YIXWRr1HiKSbpo130_provenance.